Sepsis Treatment Market (By Type: Severe Sepsis, Septic Shock, and Sepsis in Need of Blood Purification; By Therapy: Continuous Renal Replacement Therapies [CRRT], Intermittent Hemodialysis, SLEDD, Others; By End User: Hospitals, Specialty Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

According to latest report, the global sepsis treatment market reached value at US$ 600 million in 2020 and predicted to hit US$ 1.5 billion by 2030.

Sepsis is a life threatening disease caused when a chemical develops in the immune system and is released into the bloodstream. According to the Centers for Disease Control and Prevention, over 1.5 million cases of sepsis are reported globally each year.

Growth of the sepsis treatment market can be attributed to increase in patient population with infectious diseases such as COVID-19 and acute kidney injury; rise in investment by pharmaceutical and biotechnology companies in drug discovery; and surge in launch of new products for the treatment of sepsis. Presence of key players with technologically advanced products and strong geographic presence are anticipated to propel the global sepsis treatment market. Key industry events, including partnerships, mergers & acquisitions, and collaborations, are expected to fuel the growth of the global sepsis treatment market.

According to United Nations University (UNU) estimates, the percentage of the world population above 65 years of age is anticipated to increase from 9% in 2010 to 16% by 2050. Hence, increase in the population above 65 years of age asserts the need of safe and effective therapeutics for sepsis treatment. Therefore, rise in population of this group is a major driver of the market.

Increase in number of product launches and collaborations among players is a major factor propelling of the global sepsis treatment market.

Large number of drugs are under different phases of clinical trials for the treatment of sepsis. Leading companies have made significant investments in clinical R&D and have established strategic partnerships and collaborations to accelerate new product development.

Report Highlights

In terms of type, the severe sepsis segment accounted for significant share of the global market in 2020. The segment's dominance can be attributed to increase in patient population with infectious diseases such as COVID-19. According to the Global Sepsis Alliance, signs of multi-organ injury, typical of severe sepsis, occur in 2% to 5% of patients with COVID-19 after eight to 10 days.

Based on therapy, the continuous renal replacement therapies (CRRT) segment dominated the global sepsis treatment market in 2020. Increase in demand for CRRT devices for acute dialysis and various strategic decisions taken by various firms to increase CRRT production are expected to drive the segment during the forecast period. For instance, Baxter has taken a strategic decision to maximize its supply of CRRT devices, fluids, and sets to counter the unprecedented increase in demand for its acute dialysis products in Europe and the U.S.

In terms of end user, the hospitals segment accounted for major share of the market in 2020. Hospitals are an important channel for sepsis treatment. According to government healthcare facilities, hospitals have reimbursement plans and advanced technology systems for sepsis treatment. Growth of the segment can be attributed to an increase in number of hospital facilities across the world.

In terms of region, the North America is projected to be a highly attractive market during the forecast period. Well-established healthcare and life science industries, early adoption of technologically advanced products, high awareness about various infectious as well as chronic diseases, and high per capita healthcare expenditure are the major factors attributed to North America’s large market share in 2020.

The sepsis treatment market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Increase in disposable income & purchasing power of consumers, rise in biotechnology, research institutes, and research funding by government & private bodies, expansion of healthcare infrastructure, large population base, and increase in incidence of sepsis related disorders are expected to augment the sepsis treatment market in Asia Pacific during the forecast period. Economic growth of China, India, Indonesia, and other countries in Southeast Asia is likely to increase healthcare expenditure, which is projected to drive the sepsis treatment market in the region.

Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2017 to 2019.

The analysts have provided a comprehensive analysis of the competitive landscape of the global sepsis treatment market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation expected to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users) and other segments.

• Company Overview
• Company Market Share/Positioning Analysis
• Product Offerings
• Financial Performance
• Recent Initiatives
• Key Strategies Adopted by Players
• Vendor Landscape
• List of Suppliers
• List of Buyers

Key players include Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, Asahi Kasei, B. Braun Group, CytoSorbents Corporation, Medtronic plc, Nikkiso Co., Ltd., Medica SPA, Toray Industries, and Merck & Co., Inc.

Market Segmentation

By Type

• • Severe Sepsis/Sepsis
  • Septic Shock
  • Sepsis in Need of Blood Purification

By Therapy

• • Continuous Renal Replacement Therapies (CRRT)
  • Intermittent Hemodialysis
  • Sustained Low-efficiency Daily Dialysis (SLEDD)
  • Others

By End User

• • Hospitals
  • Specialty Centers
  • Others

By Region

• • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This report focuses on sepsis treatment market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall sepsis treatment market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global sepsis treatment market.

The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.

In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.

The report provides in-depth segment analysis of the global sepsis treatment market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the sepsis treatment market.

The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.

In this study, the years considered to estimate the market size of sepsis treatment are as follows:

• History Year: 2017-2019
• Base Year: 2021
• Forecast Year 2021 to 2030

Research Methodology

The research methodology adopted by analysts for compiling the global sepsis treatment market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global sepsis treatment market.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2021) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.